Table 1 Screening for disorder of haemostasis in the patient with RPL.
Parameters (unit of measurement) | Results | Normal range |
|---|---|---|
Prothrombin time (INR) | 1.15 | 0.8–1.2 |
Activated partial thromboplastin time (ratio) | 1.45 | 0.8–1.2 |
Fibrinogen (mg/dL) | 275 | 220–420 |
Protein C (%) | 93 | 60–125 |
Protein S (%) | 92 | 60–125 |
Antithrombin III (%) | 104 | 80–120 |
Anticardiolipin Ab IgM (U/GPL) | 1.7 | < 2.0 |
Anticardiolipin Ab IgG (U/MPL) | 3.9 | < 7.0 |
β-2-GP I Ab | Absent | Absent |
Lupus anticoagulant | Absent | Absent |
Factor XII (%) | 65 | 80–120 |
Factor XI (%) | 113 | 80–120 |
Factor X (%) | 112 | 80–120 |
Factor IX (%) | 99 | 80–120 |
Factor VIII (%) | 88 | 65–155 |
Factor V (%) | 110 | 80–120 |
MTHFRC677T gene polymorphism | Wild type | Wild type |
PTHRA20210 gene polymorphism | Wild Type | Wild type |
FVL gene polymorphism | Wild Type | Wild type |